Pancreatic Cancer Trial, Recruiting (NCT05346536)

Pancreatic Cancer Trial, Recruiting NCT05346536 Sponsor: University Hospital, Montpellier Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05346536 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are at least 18 years old
You have been diagnosed with pancreatic cancer that has spread to other parts of the body, and you have not yet received any treatment for it (meaning you are eligible for your first round of treatment)
You are able to give verbal agreement to take part in the trial

Who may not be able to join:

You are not covered by or entitled to benefits under a French Social Security scheme
You are considered a vulnerable person under French law (Article L1121-6) (confirm with trial site)
You are an adult who is legally protected or unable to give consent under French law (Article L1121-8) (confirm with trial site)
You are currently pregnant or breastfeeding
You may not be able to join if the trial team has concerns about your ability to attend follow-up appointments, your motivation to participate, likelihood of following the trial requirements, or if you have another serious health condition that needs to be the main focus of your care (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Catherine Alix-Panabières, PhD, University Hospital, Montpellier

Phone: +33682882757

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05346536

Sponsor: University Hospital, Montpellier

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +33682882757

More information: https://clinicaltrials.gov/study/NCT05346536

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are at least 18 years old
You have been diagnosed with pancreatic cancer that has spread to other parts of the body, and you have not yet received any treatment for it (meaning you are eligible for your first round of treatment)
You are able to give verbal agreement to take part in the trial

Who may not be able to join:

You are not covered by or entitled to benefits under a French Social Security scheme
You are considered a vulnerable person under French law (Article L1121-6) (confirm with trial site)
You are an adult who is legally protected or unable to give consent under French law (Article L1121-8) (confirm with trial site)
You are currently pregnant or breastfeeding
You may not be able to join if the trial team has concerns about your ability to attend follow-up appointments, your motivation to participate, likelihood of following the trial requirements, or if you have another serious health condition that needs to be the main focus of your care (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Montpellier

Registry

ClinicalTrials.gov

Start date

16 June 2022

Est. completion

19 September 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

CTC-AXL measurement concordance rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov